How We Work With Partners
We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.
How We Work With Partners
The full power of Zephyr’s platform, tailored to you.
From Discovery to Deployment
We make it simple to start small and scale quickly—with fast pilots, real-world validation, and population-level insights. Our multi-modal AI and enterprise-scale datasets power bespoke solutions for biopharma and diagnostics—seamlessly integrating into existing workflows; no new assays required.
For Biopharma – De-Risk Development, Accelerate Translation
Zephyr helps biopharma teams gain population-level insights and uncover biology driving response. By leveraging the full power of our multi-modal AI and enterprise-scale real-world data, we de-risk trials and accelerate translation.
Fine-tune AI models to your drug and assay for patient stratification, trial optimization, and indication expansion—including novel MOAs
For Diagnostics – Smarter Reports, Seamless Integration
Zephyr’s AI enriches reports with biological interpretability and precision insights, while enabling the co-development of AI-enabled tools for research and clinical development. Our software integrates seamlessly into existing workflows—no new assays required.
Enrich DNA or methylation panels with RUO gene expression–based signatures and precision medicine insights, validated in real-world cohorts to demonstrate performance and clinical utility
Partner with pharma and providers to co-develop tools that inform indication strategy, support label expansion and lifecycle management, drive adoption, and unlock additional value from existing or legacy LDTs
Let’s Build Together!
We support pilots, proof-of-concept studies, and full development programs. Whether you’re validating a diagnostic, generating custom cohorts, or powering market access strategies, Zephyr meets you where you are, and scales with you.